Kardium was founded in 2007 and has built an outstanding team with a track record of excellence in medicine, business, and engineering.
We have hired the best engineers, medical researchers, compliance and production staff and have been working with top medical advisers to develop the Globe mapping and ablation system. The Globe system has been entirely developed by the team at Kardium.
Kardium is based in greater Vancouver, Canada, and has consistently ranked as one of the top companies to work for in British Columbia.
Leadership and Advisors
Doug Goertzen – CEO
Doug is a co-founder and CEO of Kardium
Prior to Kardium, Doug held the position of General Manager, Proofing and Color at Eastman Kodak Company. Doug was responsible for the $55 million worldwide proofing and colour business and managed the 130 person team developing the proofing and colour product portfolio. He held senior positions in service, development and management during his 12 year tenure at Kodak and Creo Inc. (which was acquired by Kodak in 2005) and brings significant expertise in both product research and strategy to Kardium.
Doug graduated with a B.A.Sc. in electrical engineering from Simon Fraser University.
Amos Michelson – Chairman
Amos Michelson was the Chief Executive Officer of Creo Inc. from June 1995 until Kodak purchased Creo in May 2005. He joined Creo in 1991 and served in positions including Vice President Business Strategy, Managing Director, and Chair of the Board of Directors until his appointment as CEO. Under Mr. Michelson’s leadership, Creo grew to employ over 4,000 personnel and generate $650 million USD annual revenue.
Mr. Michelson holds a MBA from Stanford Business School and a B.Sc. in electrical engineering from the Technion – Israel Institute of Technology.
Dave Rosa – Director
Dave J. Rosa joined Intuitive in March 1996 and has held leadership positions in engineering, clinical development, marketing and product development. Mr. Rosa has served on the Board of Directors as the Executive Vice President and Chief Commercial Officer since June 2015. In 2014, he was promoted to the position of Executive Vice President and Chief Scientific Officer. In 2013, Mr. Rosa assumed the position of Senior Vice President, Scientific Affairs. He has been a passionate supporter and evangelist of da Vinci technology since its inception.
Mr. Rosa earned a B.S. in Mechanical Engineering from California Polytechnic University at San Luis Obispo. He also holds a Master of Science in Mechanical Engineering from Stanford University.
Ian Ihnatowycz – Director
Ian is CEO of First Generation Capital Inc., a private investment holding company. Formerly CEO of Acuity Investment Management Inc., which grew to assets of over $7.5B.
Ian holds a B.Sc. from the University of Toronto, an MBA from the Ivey Business School, and holds the CFA and Chartered Director designations.
Manuel Alba – Director
Manuel Alba’s career includes the design of consumer electronics products, marketing of technology products, executive management, and active angel investment in technology companies. Early in his career, he held technical marketing positions at National Semiconductor and IDT, both in Silicon Valley. In 1993, Mr. Alba joined Avigdor Willenz as co-founder of Galileo Technology, where he served as its President and as a Director, contributing towards its 1997 IPO and its eventual merger with Marvell Technology in 2001. Mr. Alba served as a Director of the merged company until 2004. In 2005, he joined Mr. Willenz and a small group of fellow angel investors, to actively create and help grow technology startups. Mr. Alba is currently an investor and board member in several international private technology companies, and has been a board member of various non-profit organizations in California.
Mr. Alba holds a BSEE from the National Polytechnic Institute in Mexico City, MS degrees in Computer Engineering and Engineering Management from the University of Southern California, and an MBA from Santa Clara University.
Prof. Hans Kottkamp – Medical Advisor
Prof. Kottkamp is a world renowned expert in the diagnosis and treatment of atrial fibrillation. He focuses on catheter ablation of supraventricular and ventricular arrhythmias with special emphasis on ablation of atrial fibrillation. He has more than 150 publications in international journals and monographs.
Prof. Kottkamp is on the editorial board of the Journal of Cardiovascular Electrophysiology and Heart Rhythm. His clinical work deals with all aspects of interventional cardiac electrophysiology.
Dr. Sam Lichtenstein – Co-Founder & Advisor
Dr. Sam Lichtenstein holds numerous senior medical positions including head of the UBC Division of Cardiovascular Surgery.
Dr. Lichtenstein is a renowned practitioner and researcher in cardiovascular surgery and has made significant contributions to heart surgery techniques during his career.
Dan Gelbart – Co-Founder & Advisor
Dan is an inventor who has more than 100 U.S. Patents to his name. Dan co-founded Creo Inc. in 1984 and served as President and then CTO until July, 2005, when Creo was sold to Kodak for $1 Billion USD.
He holds Master of Science in Electrical Engineering from the Technion in Israel. Dan was twice awarded the British Columbia Science Council gold medal, the Institute of Printing gold medal, honorary doctorates from Simon Fraser University and University of British Columbia.
Kevin Chaplin – Vice President, Business Development
Kevin is the Vice President of Business Development and has been with Kardium since 2008. Prior to Kardium, Kevin has held product management and marketing positions at Kodak and Sierra Wireless.
Kevin has a Bachelor of Science in Chemical Engineering degree from the University of Cape Town.